$136,265,880
to TRUSTEES OF BOSTON UNIVERSITY
NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Operates the National Emerging Infectious Diseases Laboratories at Boston University for research on dangerous pathogens.
Critical biosafety infrastructure for studying high-threat infectious diseases and developing countermeasures to emerging pandemic threats.
Drives demand for specialized biosafety equipment, containment systems, diagnostic reagents, and trained personnel in biodefense sectors.
U.S. maintains advanced BSL-4 laboratory capacity for pandemic preparedness and biodefense, an area of strategic competition with China.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002218.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_UC7AI095321_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.